Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 28, 2024 (Week 52)
Reporting Area Gonorrhea §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 3,328 12,471 494,259 601,262
New England 116 450 13,736 16,977
Connecticut 27 85 2,555 4,098
Maine - 25 594 620
Massachusetts 67 218 8,596 9,786
New Hampshire - 23 525 588
Rhode Island 20 212 1,285 1,665
Vermont 2 10 181 220
Middle Atlantic 421 1,573 67,925 74,994
New Jersey 107 236 9,283 10,134
New York (excluding New York City) 177 304 12,235 13,552
New York City - 758 28,852 32,550
Pennsylvania 137 416 17,555 18,758
East North Central 256 1,583 59,723 77,344
Illinois 15 510 15,965 25,387
Indiana 65 217 8,249 9,881
Michigan 22 319 12,238 15,274
Ohio 139 398 16,856 19,795
Wisconsin 15 170 6,415 7,007
West North Central 207 649 28,034 33,979
Iowa 32 83 3,161 3,747
Kansas 23 90 3,015 4,234
Minnesota 26 182 7,074 7,717
Missouri 126 260 10,297 12,513
Nebraska - 64 1,910 2,285
North Dakota - 25 767 1,154
South Dakota - 56 1,810 2,329
South Atlantic 1,137 4,682 131,800 150,262
Delaware - 40 1,388 1,567
District of Columbia 9 140 5,549 5,794
Florida 445 2,715 41,166 46,726
Georgia 233 643 27,330 30,307
Maryland 133 304 10,855 12,802
North Carolina - 514 20,129 26,353
South Carolina 130 290 11,224 11,950
Virginia 183 314 13,490 13,795
West Virginia 4 27 669 968
East South Central 172 616 18,226 38,324
Alabama 99 230 8,766 11,584
Kentucky 50 223 4,760 6,072
Mississippi 23 294 4,700 7,382
Tennessee - 162 - 13,286
West South Central 151 1,534 67,305 79,822
Arkansas 21 146 5,042 5,932
Louisiana 68 254 10,453 13,192
Oklahoma 12 94 3,965 6,905
Texas 50 1,126 47,845 53,793
Mountain 128 696 30,267 36,302
Arizona 8 292 12,337 14,172
Colorado 81 189 6,208 7,563
Idaho 4 27 662 777
Montana 3 28 739 767
Nevada - 155 5,292 6,538
New Mexico 12 73 2,679 3,574
Utah 20 62 2,163 2,664
Wyoming - 9 187 247
Pacific 740 1,827 77,243 93,258
Alaska 26 55 2,047 2,280
California 499 1,453 62,035 74,071
Hawaii - 21 - 1,818
Oregon 55 133 4,417 4,960
Washington 160 312 8,744 10,129
U.S. Territories - 16 37 1,187
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 16 37 1,187
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 2 19 25
Total 3,329 12,476 494,315 602,474
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, confirmed and probable cases only are being published to align with the approved CSTE position statement 22-ID-03, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.
Notes:
  • These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly in alphabetical order by condition. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Weekly tables since 1996 are available on CDC WONDER.
  • Weekly tables since 2014 are available on Data.CDC.gov.
  • Weekly tables for 1952–2017 published in the Morbidity and Mortality Weekly Reports (MMWR) are available at CDC Stacks MMWR, and weekly tables starting in 2018 are available at CDC Stacks NNDSS (once in CDC Stacks NNDSS select "Weekly Tables" in the "Genre" box at the left).
  • Notices, errata, and other notes are available in the Notice To Data Users page.
  • The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.
Suggested Citation:
  • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data. Atlanta, GA. Office of Public Health Data, Surveillance, and Technology. Available at: https://www.cdc.gov/nndss/data-statistics/index.html.
Acknowledgment:
  • CDC acknowledges the local, state, and territorial health departments that collected the data from a range of case ascertainment sources (e.g., health-care providers, hospitals, laboratories) and reported these data to CDC's National Notifiable Diseases Surveillance System.